MONDAY, April 10, 2023 (HealthDay News) — The U.S. Food and Drug Administration has issued another warning about certain sleep apnea machines made by Philips Respironics. Already the subject of a 2021 recall, some of the company’s repaired continuous positive airway pressure (CPAP) machines may still be dangerous to use,Continue Reading
MONDAY, April 10, 2023 (HealthDay News) — Seasonal allergies are more common among Black and Hispanic people, but these patients are less likely to get the shots that could ease their symptoms, researchers say. “We already know that these underrepresented populations are more likely to suffer from allergic rhinitis [hayContinue Reading
FRIDAY, April 7, 2023 (HealthDay News) — New research suggests that gender and money matter when it comes to getting a last-resort treatment after mechanical ventilation. Funded by the U.S. National Institutes of Health, the study found that certain groups are more likely to receive advanced pulmonary support through ECMOContinue Reading
TUESDAY, April 4, 2023 (HealthDay News) — A good night’s sleep is important for everyone, and it may be especially sage advice for adults with a genetic susceptibility to asthma, a new study says. Someone with poor sleep quality and a genetic link to asthma may double their chances ofContinue Reading
TUESDAY, March 28, 2023 (HealthDay News) — If you’re one of the millions of people with allergic asthma or eczema, you may be more likely to develop the wear-and-tear form of arthritis as you age. This is the main finding from a new study that examined the risk of developingContinue Reading
MONDAY, March 27, 2023 (HealthDay News) — While all Americans could benefit from proposed new limits on what’s called PM2.5 air pollution, new research indicates the change has the potential to benefit Black and low-income Americans the most. The limits being considered by the U.S. Environmental Protection Agency (EPA) couldContinue Reading
THURSDAY, March 23, 2023 (HealthDay News) — Tuberculosis cases climbed again in 2022, U.S. health officials announced Thursday. Still, the 5% increase, which amounted to 8,300 cases, didn’t reach higher pre-pandemic numbers, according to the U.S. Centers for Disease Control and Prevention. “The message is loud and clear — TBContinue Reading
WEDNESDAY, March 15, 2023 (HealthDay News) — Black patients are dying of pulmonary fibrosis, a devastating disease marked by progressive scarring of the lungs, at significantly younger ages than white patients. A new study probes factors contributing to earlier onset of disease, hospitalization and death in Black patients. The diseaseContinue Reading
SUNDAY, March 12, 2023 (HealthDay News) — Planning for a safe summer camp experience requires some extra steps if your child has asthma or allergies. An allergy expert noted that it’s a huge concern for parents. “Most kids heading off to summer camp for the first time wonder how they’llContinue Reading
THURSDAY, March 9, 2023 (HealthDay News) — Ongoing shortages of a medication that hospitals and emergency rooms rely upon to treat breathing problems are likely to worsen in coming days and weeks, experts warn. That’s because one of the two major U.S. suppliers of liquid albuterol, Akorn Pharmaceuticals, abruptly laidContinue Reading
TUESDAY, March 7, 2023 (HealthDay News) — A new study is enough to take your breath way: Nearly no place on Earth is free of air pollution, it found. The study “provides a deep understanding of the current state of outdoor air pollution and its impacts on human health. WithContinue Reading
THURSDAY, March 2, 2023 (HealthDay News) — Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV vaccine, this one made by GlaxoSmithKline, for use in Americans ages 60 and older. The panel’s recommendation was based largelyContinue Reading
WEDNESDAY, March 1, 2023 (HealthDay News) — In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up. The vaccine, known as RENOIR, was developed by pharmaceutical giant Pfizer Inc. The sameContinue Reading
MONDAY, Feb. 27, 2023 (HealthDay News) – Children in Sweden’s capital can breathe a little easier. As Stockholm’s air has gotten cleaner, young people’s lungs have gotten stronger, new research shows. The findings could have implications for cities worldwide. While the adverse impact of air pollutants on kids’ lung healthContinue Reading